MedPath
TGA Approval

Idarubicin hydrochloride injection 20 mg in 20 mL (1) (315486)

315486

Idarubicin hydrochloride injection 20 mg in 20 mL (1)

Pfizer (Perth) Pty Ltd

March 18, 2019

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

idarubicin hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Idarubicin hydrochloride injection 20 mg in 20 mL (1) (315486) - TGA 批准文号 | MedPath